Roche Holding AG ROG-CH:Swiss Exchange

*Data is delayed | CHF
Last | 08/12/22 CEST
315.00quote price arrow up+4.85 (+1.56%)
Volume
873,382
52 week range
298.30 - 404.20
Loading...
  • Open311.50
  • Day High315.80
  • Day Low311.00
  • Prev Close310.15
  • 52 Week High404.20
  • 52 Week High Date04/11/22
  • 52 Week Low298.30
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap267,994.17M
  • Shares Out800.58M
  • 10 Day Average Volume969,474.4
  • Dividend9.30
  • Dividend Yield2.95%
  • Beta0.8
  • YTD % Change-16.91

KEY STATS

  • Open311.50
  • Day High315.80
  • Day Low311.00
  • Prev Close310.15
  • 52 Week High404.20
  • 52 Week High Date04/11/22
  • 52 Week Low298.30
  • 52 Week Low Date06/16/22
  • Market Cap267,994.17M
  • Shares Out800.58M
  • 10 Day Average Volume969,474.4
  • Dividend9.30
  • Dividend Yield2.95%
  • Beta0.8
  • YTD % Change-16.91

RATIOS/PROFITABILITY

  • EPS (TTM)16.52
  • P/E (TTM)19.07
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Roche Holding AG

There is no recent news for this security.

Profile

MORE
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...
Christoph Franz Ph.D.
Non-Executive Independent Chairman of the Board
Severin Schwan
Chief Executive Officer, Executive Director, Member of the Corporate Executive
Alan Hippe
Member of the Corporate Executive Committee, Chief Financial and Information Officer
Claudia Boeckstiegel
Member of the Enlarged Corporate Executive Committee, General Counsel
Address
Grenzacherstrasse 124
Basel
4058
Switzerland